- Home
- ARTW vs CYCN Comparison
ARTW vs CYCN Comparison
Compare ARTW & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- CYCN
- Stock Information
- Founded
- ARTW 1956
- CYCN 2018
- Country
- ARTW United States
- CYCN United States
- Employees
- ARTW N/A
- CYCN N/A
- Industry
- ARTW Industrial Machinery/Components
- CYCN Biotechnology: Pharmaceutical Preparations
- Sector
- ARTW Industrials
- CYCN Health Care
- Exchange
- ARTW Nasdaq
- CYCN Nasdaq
- Market Cap
- ARTW 8.6M
- CYCN 8.4M
- IPO Year
- ARTW N/A
- CYCN N/A
- Fundamental
- Price
- ARTW $1.68
- CYCN $2.82
- Analyst Decision
- ARTW
- CYCN
- Analyst Count
- ARTW 0
- CYCN 0
- Target Price
- ARTW N/A
- CYCN N/A
- AVG Volume (30 Days)
- ARTW 32.5K
- CYCN 5.8M
- Earning Date
- ARTW 02-11-2025
- CYCN 03-04-2025
- Dividend Yield
- ARTW N/A
- CYCN N/A
- EPS Growth
- ARTW 17.02
- CYCN N/A
- EPS
- ARTW 0.06
- CYCN N/A
- Revenue
- ARTW $24,499,371.00
- CYCN $194,000.00
- Revenue This Year
- ARTW N/A
- CYCN N/A
- Revenue Next Year
- ARTW N/A
- CYCN N/A
- P/E Ratio
- ARTW $27.78
- CYCN N/A
- Revenue Growth
- ARTW N/A
- CYCN N/A
- 52 Week Low
- ARTW $1.33
- CYCN $1.27
- 52 Week High
- ARTW $4.15
- CYCN $9.47
- Technical
- Relative Strength Index (RSI)
- ARTW 45.62
- CYCN 43.92
- Support Level
- ARTW $1.61
- CYCN $2.89
- Resistance Level
- ARTW $1.77
- CYCN $4.80
- Average True Range (ATR)
- ARTW 0.11
- CYCN 0.66
- MACD
- ARTW -0.00
- CYCN -0.13
- Stochastic Oscillator
- ARTW 25.81
- CYCN 6.03
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world-wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.